Insider Transactions in Q4 2025 at An2 Therapeutics, Inc. (ANTX)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 04
2025
|
Stephen David Prior Chief Strategy Officer |
SELL
Open market or private sale
|
Direct |
765
-1.15%
|
$765
$1.14 P/Share
|
|
Nov 04
2025
|
Joshua M Eizen |
SELL
Open market or private sale
|
Direct |
2,819
-1.56%
|
$2,819
$1.14 P/Share
|
|
Oct 10
2025
|
Patricia A. Martin |
BUY
Grant, award, or other acquisition
|
Direct |
3,274
+19.81%
|
-
|
|
Oct 10
2025
|
Kabeer Aziz |
BUY
Grant, award, or other acquisition
|
Direct |
10,367
+20.21%
|
-
|
|
Oct 10
2025
|
Gilbert Lynn Marks |
BUY
Grant, award, or other acquisition
|
Direct |
10,367
+13.99%
|
-
|